Filter by: patients
Home > Community Treatment Reports and Side Effects > Gaviscon Extra Strength Treatment Report
What is Gaviscon Extra Strength?

Gaviscon® Extra Strength is a brand name product that contains aluminum hydroxide and magnesium carbonate. It is used for temporary relief of symptoms associated with gastric acidity.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Acid reflux 3 1 Efficacy_moderate
GERD (Gastroesophageal reflux disease) 1 1 Efficacy_slight

See all 4 patients currently taking Gaviscon Extra Strength

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 0
None
 1

Reported Dosages

  10mg as needed 254mg-237.5mg/5mL as needed 8 other daily 254 mg-237.5 mg/5 mL daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Gaviscon Extra Strength (multiple reasons could be selected)
Reason # Patients Percentage of patients
Personal research 1   Personal research: 100%

See all 1 patient who’ve stopped taking Gaviscon Extra Strength

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Gaviscon Extra Strength

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Gaviscon Extra Strength

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Gaviscon Extra Strength

Always
 2 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Gaviscon Extra Strength

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 2 100%

Cost

Paid out of pocket

Cost of Gaviscon Extra Strength

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

Report created on February 12, 2012.